PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 1,904 shares of the business's stock in a transaction dated Thursday, October 29th. The shares were sold at an average price of $50.05, for a total transaction of $95,295.20. Following the completion of the transaction, the chief executive officer directly owned 54,179,397 shares of the company's stock, valued at $2,711,678,819.85. The trade was a 0.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total transaction of $345,639.90.
- On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total transaction of $3,349,366.20.
- On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total transaction of $651,244.80.
- On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total transaction of $314,768.20.
- On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
- On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.
- On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
- On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The stock was sold at an average price of $47.27, for a total transaction of $5,201,354.45.
- On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00.
- On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.
PACS Group Trading Down 3.9%
Shares of PACS Group stock traded down $1.92 during trading hours on Friday, reaching $47.76. 591,191 shares of the company's stock were exchanged, compared to its average volume of 824,846. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $50.38. The firm has a market capitalization of $7.56 billion, a price-to-earnings ratio of 27.77, a price-to-earnings-growth ratio of 1.55 and a beta of -0.08. The company has a fifty day moving average of $44.21 and a 200-day moving average of $39.79. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.21.
PACS Group (NYSE:PACS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to analysts' expectations of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Sell-side analysts forecast that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of brokerages have issued reports on PACS. Royal Bank Of Canada raised their price target on PACS Group from $52.00 to $57.00 and gave the stock an "outperform" rating in a research note on Thursday, August 6th. Weiss Ratings raised shares of PACS Group from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, October 8th. Truist Financial set a $62.00 price objective on shares of PACS Group in a report on Wednesday, September 2nd. JPMorgan Chase & Co. raised their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research report on Friday, September 4th. Finally, Wall Street Zen downgraded shares of PACS Group from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 8th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $58.80.
Read Our Latest Report on PACS
Institutional Trading of PACS Group
Institutional investors and hedge funds have recently made changes to their positions in the company. Financial Management Professionals Inc. raised its position in shares of PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company's stock worth $28,000 after buying an additional 235 shares during the period. GK Wealth Management LLC purchased a new stake in PACS Group during the third quarter valued at about $41,000. USA Financial Formulas acquired a new stake in PACS Group during the third quarter worth about $46,000. KBC Group NV acquired a new stake in PACS Group during the first quarter worth about $42,000. Finally, Western Wealth Management LLC acquired a new stake in PACS Group during the first quarter worth about $48,000.
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.